CAS: 129101-25-3; 2-((Tert-Butoxycarbonyl)Amino)-3-(4-Fluorophenyl)Propanoic Acid

该化合物是一种受保护的氨基酸衍生物,广泛用于丙二酸合成和制药研究中;三丁氧碳基(Boc)组在基本条件下提供稳定性,同时允许在酸条件下有选择地进行非保护,使其对正方保护战略具有价值;四氟苯基在医药化学中增强了其效用,特别是用于设计针对CNS紊乱或酶抑制的生物活性化合物;该化合物表现出高度纯度和连续的再活动,确保固相和溶液相聚反应的可靠性能;其结构特征使它成为合成氟化或小型分子疗法的多用途中间体,其代谢稳定性和结合性得到提高.

结构式图片

相似化合物

169243-86-1 177966-64-2 18125-46-7

欧盟法规

C&L通报

上下游产品

2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile L-4-fluorophenylalanine tert-butyl dicarbonatedi-tert-butyl dicarbonate 4-FluorophenylalanineB°C-Phe(4-F)-NMeBzl

合成工艺路线路线简述

    📜二碳酸二叔丁酯,Dl-对氟苯丙氨酸置于sodium Hydroxide体系中,用 1,4-二氧六环,水 用作溶剂,化学反应 0.5H,以100%的收率获得boc-Dl-4-氟苯丙氨酸
    参考文献:使用staudinger反应固相合成β-内酰胺,通过19 F NMR光谱监测
    标题:使用staudinger反应固相合成β-内酰胺,通过19 F NMR光谱监测
    摘要:我们报告了使用19 F NMR作为监测固相反应的简单方法.在涉及氟化α-氨基酯,醛和酰氯的多组分反应的情况下,描述了包括保护,偶联,脱保护,缩合,环加成和裂解步骤在内的多步骤序列.
    Doi:10.1016/s0040-4020(03)00553-2

    海关参考信息

    专利信息


    专利号:US-11453699-B2
    优先权日:2017-04-19
    标 题:Antimicrobial compounds and/or modulators of microbial infections and methods of using the same
    发明人:SCOTT WILLIAM LEONARD; O'DONNELL MARTIN JAMES; SAMARITONI JACK GENO
    权利人:UNIV INDIANA RES & TECH CORP
    摘要:Some embodiments include compounds that can inhibit the growth of bacterial and/or inhibit or reduce microbial infections caused by one or more microorganisms (e.g., Pseudomonas aeruginosa and Cryptococcus neoformans) and methods of using these compounds to treat microbial infection and outbreaks and/or to reduce the formation of biofilms. Other embodiments include synthesis of the compounds that can inhibit the growth of one or more microorganisms and/or inhibit or reduce microbial infections.

    专利号:US-6872745-B2
    优先权日:2000-04-14
    标 题 :Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
    发明人:JOHNSON JR THEODORE O; HUA YE; LUU HIEP T; DRAGOVICH PETER S
    权利人:AGOURON PHARMA
    摘要:Compounds of the formula: n n nwhere the formula variables are as defined in the disclosure, advantageously inhibit or block the biological activity of the picornaviral 3C protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with one or more picornaviruses, such as RVP. Intermediates and synthetic methods for preparing such compounds are also described.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Photoredox/cobalt Dual‐catalyzed Decarboxylative Elimination Of Carboxylic Acids: Development And Mechanistic Insight
    作者:Kaitie C. Cartwright,Ebbin Joseph,Chelsea G. Comadoll,Jon A. Tunge |发布日期:2020.9.25
    摘要:Recently, Dual‐catalytic Strategies Towards The Decarboxylative Elimination Of Carboxylic Acids Have Gained Attention. Our Lab Previously Reported A Photoredox/cobaloxime Dual Catalytic Method That Allows The Synthesis Of Enamides And Enecarbamates Directly From N‐acyl Amino Acids And Avoids The Use Of Any Stoichiometric Reagents. Further Development, Detailed Herein, Has Improved Upon This Transformation'S

    合成参考文献

    合成方法参考DOI号:10.1016/S0040-4020(03)00553-2
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知